| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |